NBScience

What NBScience does

NBScience is a London-based clinical research organization that describes itself, per its own Terms and Conditions, as a group of private individuals from different countries rather than a formally incorporated legal entity. Its functional activity spans three interlocking offerings: a contract research / GCP compliance practice (clinical trial coordination, GCP auditing, regulatory documentation, and inspection readiness aligned with European Medicines Agency frameworks), a professional training and certification catalog (GCP, GCP auditor, GDP/GMP/CQA, and GMP programs), and a regenerative-medicine consultation and treatment-coordination service delivered primarily to international high-net-worth patients seeking stem cell and cell-based therapies in Europe.

The company monetizes through professional-services fees on a quote / pay-as-you-go basis. Stem cell therapy protocols are priced from approximately $6,000–$9,000 for local or joint injections and $6,000–$50,000 for intravenous infusions, with a representative published rate of €7,400 for a 40-million-cell IV infusion; MSC exosome products are listed at €485 for 50ml. Customer acquisition is content-driven: 163+ pages of multilingual educational material in eight languages support organic search and a bottom-of-funnel medical-evaluation pathway funneled through WhatsApp, email, and contact forms in the UK, France, and Spain. The Barcelona-based NBS Stem Cell Clinic (Carrer del dos de Maig, 301) is the only disclosed owned clinical site; other treatment delivery is routed through a network of partner medical centers across the UK, Spain, Switzerland, Italy, Greece, and Slovakia.

The organization is founder-led by Dr. Eugene Zadorin (MD 2000, PhD Cardiology 2005, 25+ years' experience, 40+ peer-reviewed publications), with no disclosed institutional investors, parent company, funding rounds, patents, or formal corporate ownership structure. Customer evidence is thin: testimonial cases date to 2009–2010, the most recent third-party recognition is a 2018 WhatClinic Customer Service Award, and no enterprise customer logos, recurring revenue contracts, or audited financials are disclosed.

Name

NBScience

Legal name

NBScience (not a formal legal entity; maintained by private individuals)

Website

https://nbscience.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

101–250 employees

Short description

NBScience is a London-based, founder-led clinical research organization offering GCP compliance and training services alongside regenerative-medicine consultation and stem cell therapy coordination for international high-net-worth patients across Europe.

Ownership category

akta.pro rank

Product category

Contract Research Organization

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)

Keywords

• Clinical research services
• Stem cell therapy
• GCP certification training
• Regenerative medicine consultation
• GMP audit services

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Others

Revenue model

1. Clinical Research Services: Support services for clinical research activities including trial coordination, GCP auditing, regulatory compliance, and training programs
2. Regenerative Medicine Consultation: Medical consultation services for regenerative medicine approaches, including medical record review and scientific orientation for international patients
3. Stem Cell Therapy Services: Stem cell treatment services including induced pluripotent stem cells (iPSC), embryonic stem cells, autologous stem cells, and allogeneic stem cell therapies

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

NBScience is a contract research organization providing clinical research support services (trial coordination, GCP auditing, regulatory documentation), professional training and certification programs (GCP, GMP/GDP/CQA), and regenerative medicine information and consultation. The organization also operates the NBS Stem Cell Clinic in Barcelona offering advanced stem cell therapies including induced pluripotent stem cell (iPSC), embryonic, autologous, and allogeneic treatments, and coordinates care for international patients across European clinics.

Product overview

NBScience is a contract research organization operating at the intersection of clinical research, biotechnology, and scientific collaboration. The company offers a portfolio of clinical research support services (GCP compliance, auditing, regulatory documentation), professional training and certification programs (GCP, auditor, GMP/GDP audit training), and regenerative medicine information services. The core offerings include: Clinical Research Support Services for trial coordination and compliance; GCP Training and Certification Programs for healthcare professionals; Regenerative Medicine Information Services covering cell-based therapies and translational research; GMP/GDP Audit and Training Services; and the NBS Stem Cell Clinic Barcelona providing stem cell therapy treatments including iPSC, embryonic stem cell, autologous, and allogeneic approaches.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Support Services Comprehensive clinical research coordination and support services aligned with international Good Clinical Practice (GCP) standards, including trial coordination, regulatory compliance, and documentation support for clinical studies. Targeted at clinical investigators, study teams, research sponsors, and pharmaceutical organizations.
• GCP Training and Certification Programs Online professional training and certification programs for healthcare and research professionals covering Good Clinical Practice (GCP), including online courses and auditor certification. Targeted at clinical investigators, study teams, and research professionals.
• GMP/GDP Audit and Training Services Quality compliance training and auditing services covering Good Manufacturing Practice (GMP), Good Distribution Practice (GDP), and Clinical Quality Assurance (CQA) standards, including auditor certification. Targeted at pharmaceutical and biotech quality professionals.
• Regenerative Medicine Consultation Services Scientific orientation, medical record review, and personalized treatment consultation services for international patients seeking regenerative and preventive medical approaches. Targeted at high-net-worth individuals and executives seeking advanced medical evaluation.
• NBS Stem Cell Clinic Barcelona Stem cell therapy clinic located in Barcelona, Spain (Carrer del dos de Maig, 301, 08025 Barcelona) offering advanced regenerative medicine treatments including induced pluripotent stem cell (iPSC), embryonic stem cell, autologous, and allogeneic stem cell therapies. Targeted at international patients seeking advanced regenerative treatments.
• Stem Cell and Cellular Research Research activities focused on stem cells and cellular models, including cellular mechanisms, differentiation processes, biological characterization, and experimental models for therapeutic development within structured research frameworks. Targeted at academic and clinical research institutions.

Quantifiable outcome

• HbA1C improvement from 7.8% to 6.1% in diabetes patient following stem cell treatment
• +1 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Parexel International: Parexel is a global CRO providing clinical operations, regulatory, and biopharmaceutical services. Comparable to NBScience's clinical trial coordination and regulatory compliance offerings, though at established CRO scale with dedicated sponsor portfolios.
• Medpace: Medpace is a mid-to-large CRO offering full-service clinical trial management across therapeutic areas. Comparable in clinical operations and GCP-aligned coordination services to NBScience, though at meaningful scale with sponsor-funded trial pipelines.
• IQVIA: IQVIA is the world's largest CRO offering clinical trial coordination, real-world evidence, and consulting services to pharma sponsors. Comparable to NBScience's clinical research support and GCP-adjacent service lines, but operating at vastly broader global scale with full sponsor relationships.
• Charles River Laboratories: Charles River provides CRO, CDMO, and research models services spanning preclinical through clinical, including cell and gene therapy support. Comparable to NBScience's stem cell research participation and clinical research services, particularly in the regenerative medicine niche.

Direct peers

• CITI Program: CITI Program provides online research ethics, GCP, and biosafety training and certification used globally by investigators and IRBs. Directly comparable to NBScience's GCP and auditor training/certification programs, representing the dominant incumbent in research professional certification.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-tier CRO providing clinical operations, biometrics, and regulatory consulting to biopharma. Directly comparable to NBScience's clinical trial coordination, GCP auditing, and regulatory documentation service lines.
• Clinipace Worldwide: Clinipace is a mid-tier CRO offering clinical research, biostatistics, and regulatory services to emerging and mid-sized biopharma. Directly comparable to NBScience's CRO and clinical research support offerings at a similar scale and client profile.
• Emmes: Emmes is a mid-size CRO focused on clinical research across biomedical and behavioral health areas, including cell and gene therapy trials. Directly comparable to NBScience's clinical research support and translational research positioning, particularly for regenerative medicine sponsors.
• Premier Research: Premier Research is a CRO specializing in small-to-mid sized biopharma clients across neurology, oncology, and rare diseases. Comparable to NBScience's CRO-style service offerings and training programs, including support for regenerative and advanced therapy sponsors.

Emerging players

• Regenexx: Regenexx is an emerging network of regenerative medicine clinics offering autologous stem cell treatments for orthopedic and chronic conditions. Comparable to NBScience's Barcelona stem cell clinic and direct-to-consumer regenerative medicine positioning, with similar patient testimonials rather than RCT data.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/nbscience
• Facebookfacebook.com/NBScienceStemCells
• LinkedInlinkedin.com/company/nbscience

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NBScience